专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110015437A1 USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS 有权
标题翻译：苯丙胺胺和羟肟酸作为甲氧苄啶受体配体的使用
公开(公告)号：US20110015437A1
公开(公告)日：2011-01-20
申请号：US12892402
申请日：2010-09-28
申请人： Torbjörn Lundstedt , Anna Skottner , Elisabeth Seifert
发明人： Torbjörn Lundstedt , Anna Skottner , Elisabeth Seifert
IPC分类号： C07C281/16 , C07C53/10
CPC分类号： C07C281/16 , A61K31/155 , C07C53/10 , C07C309/30 , C07C309/46 , C07D317/58
摘要： The present invention relates to the use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: wherein X is H or OH; R1, R2, R3, R4 and R5 are the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, electron donor groups such as alkoxy having 1-5 carbon atoms or hydroxy, electron acceptor groups selected from cyano, nitro, trifluoroalkyl or amide; alkylamino, benzoyloxy, nitroxy, phenyl or sulpho; and the pharmacologically active salts thereof.
摘要翻译：本发明涉及通式（I）的化合物作为黑皮质素受体的配体和/或用于治疗黑皮质素系统中的病症的用途：其中X是H或OH; R 1，R 2，R 3，R 4和R 5相同或不同，选自氢，卤素，具有1-5个碳原子的烷基，电子给体基团如具有1-5个碳原子的烷氧基或羟基，电子受体基团选自氰基，硝基，三氟烷基或酰胺; 烷基氨基，苯甲酰氧基，硝酰基，苯基或磺基; 及其药理学活性盐。

2. 发明申请

US20080275129A1 Methods and Pharmaceutical Compositions for the Treatment of Neurological Damage 审中-公开
标题翻译：用于治疗神经损伤的方法和药物组合物
公开(公告)号：US20080275129A1
公开(公告)日：2008-11-06
申请号：US11885594
申请日：2006-03-06
申请人： Torbjorn Lundstedt , Elisabeth Seifert , Per Lek , Arne Boman , Anna Skottner
发明人： Torbjorn Lundstedt , Elisabeth Seifert , Per Lek , Arne Boman , Anna Skottner
IPC分类号： A61K31/155 , A61P25/00
CPC分类号： A61K31/155
摘要： The invention relates to a method of treating neurological damage, preferably spinal chord injury, said treatment comprising the topical administration of guanabenz. The invention also relates to the use of guanabenz for the preparation of a medicament for the treatment of neurological damage, preferably spinal chord injury, wherein said treatment comprises the topical administration of guanabenz to the site of said neurological damage. The invention is also directed to pharmaceutical compositions comprising guanabenz wherein said compositions are in the form of an aqueous gel or non-aqueous ointment.
摘要翻译：本发明涉及一种治疗神经损伤的方法，优选脊髓损伤，所述治疗包括局部给予胍那苯。本发明还涉及胍苯醌用于制备用于治疗神经损伤（优选脊髓损伤）的药物的用途，其中所述治疗包括将神经系统局部施用于所述神经损伤部位。本发明还涉及包含胍苯甲酸酯的药物组合物，其中所述组合物为水性凝胶或非水性软膏剂的形式。

3. 发明授权

US07153881B2 Compounds acting as melanocortin receptor ligands 有权
标题翻译：作为黑皮质素受体配体的化合物
公开(公告)号：US07153881B2
公开(公告)日：2006-12-26
申请号：US10343326
申请日：2001-08-07
申请人： Torbjörn Lundstedt , Anna Skottner , Arne Boman , Per Andersson , Victor Andrianov , Ivars Kalvins
发明人： Torbjörn Lundstedt , Anna Skottner , Arne Boman , Per Andersson , Victor Andrianov , Ivars Kalvins
IPC分类号： A61K31/415 , C07D231/56
CPC分类号： C07D213/53 , A61K31/155 , A61K31/40 , A61K31/44 , C07C281/18 , C07D209/14 , C07D209/40 , C07D213/74 , C07D401/12 , C07D405/12
摘要： The present invention provides novel compounds and use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: Wherein X and Y are independently chosen from O, N, S and (CH2)n, where n is 0, 1, 2, 3, 4, or 5, or a combination of these and may contain carbon-carbon multiple bonds and branched chains as well as alicyclic and heterocyclic groups; Q is H or OH; R1 and R2 can be either the same or different and are chosen from hydrogen or the residue of an aromatic group as listed in Scheme 1 and the pharmacologically active salts thereof
摘要翻译：本发明提供新的化合物和通式（I）的化合物作为黑皮质素受体的配体和/或用于治疗黑皮质素系统中的病症的用途：其中X和Y独立地选自O，N，S和（CH 其中n为0,1,2,3,4或5，或它们的组合，并且可以含有碳 - 碳多重键和支链以及脂环族和杂环基团; Q是H或OH; R 1和R 2可以相同或不同，并且选自氢或如方案1所列的芳族基团的残基和其药理学活性盐

4. 发明申请

US20100098629A1 Novel Amides Acting on the Adenosine Receptors 有权
标题翻译：新型酰胺作用于腺苷受体
公开(公告)号：US20100098629A1
公开(公告)日：2010-04-22
申请号：US12514634
申请日：2007-11-09
申请人： Torbjorn Lundstedt , Elisabeth Seifert , Per Lek , Arne Boman
发明人： Torbjorn Lundstedt , Elisabeth Seifert , Per Lek , Arne Boman
IPC分类号： A61K31/404 , C07D209/14 , A61K51/04 , A61P29/00 , A61P19/02 , A61P25/00
CPC分类号： C07D209/14
摘要： There are described Compounds of formula (I) in which R3 to R8 are independently selected from hydrogen, halogen, trihaloalkyl, alkyl having 1, 2, 3, 4 or 5 carbon atoms, electron donor groups selected from alkoxy having 1, 2, 3, 4 or 5 carbon atoms, trihaloalkoxy, hydroxy or amino, electron acceptor groups selected from cyano, sulphonic, nitro, or amide; R1 is an optionally substituted phenyl, benzyl or cyclohexyl group; R2 is selected from amino, substituted amino or guanidino groups, Z is a saturated or unsaturated C1-5 hydrocarbon chain, and salts thereof. A process for their preparation and compositions containing them are also described. The Compounds are either agonists or antagonists of a specific adenosine receptor or a number of adenosine receptors and have usefulness for the treatment of inflammation, arthritic conditions, rheumatoid arthritis, Osteoarthritis, mental disorders, or for inducing central nerve regeneration.
摘要翻译：描述了其中R 3至R 8独立地选自氢，卤素，三卤代烷基，具有1,2,3,4或5个碳原子的烷基的式（I）化合物，选自具有1,2,3或4个碳原子的烷氧基的电子给体基团 4或5个碳原子，三卤代烷氧基，羟基或氨基，选自氰基，磺酸，硝基或酰胺的电子受体基团; R1是任选取代的苯基，苄基或环己基; R2选自氨基，取代的氨基或胍基，Z是饱和或不饱和的C 1-5烃链及其盐。还描述了其制备方法和含有它们的组合物。化合物是特定腺苷受体的激动剂或拮抗剂或多种腺苷受体，并且可用于治疗炎症，关节炎病症，类风湿性关节炎，骨关节炎，精神障碍或诱导中枢神经再生。

5. 发明申请

US20100056641A1 Novel Aminoguanidines as Melanocortin Receptor Ligands 有权
标题翻译：新型氨基胍作为黑皮质素受体配体
公开(公告)号：US20100056641A1
公开(公告)日：2010-03-04
申请号：US12518335
申请日：2007-12-13
申请人： Torbjorn Lundstedt , Elisabeth Seifert , Per Lek , Arne Boman
发明人： Torbjorn Lundstedt , Elisabeth Seifert , Per Lek , Arne Boman
IPC分类号： A61K31/155 , C07C277/08 , A61P37/06
CPC分类号： C07D339/08 , C07C281/18 , C07C323/48
摘要： There are described compounds of general formula (I) and isomeric forms thereof wherein n is 0, 1, 2 or 3, saturated or unsaturated; most preferably at least one of R1 to R5 represents halogen; at least one of R1, R2, R3, R4 and R5 is selected from —S—R or —COOR, or two or more Of R1-R5 comprise a linking group such as —S—(CH2)mS—, where m is 1, 2 or 3 and R is selected from alkyl having 1 to 5 carbon atoms, cycloalkyl having 3-6 carbon atoms, hydroxy, and aryl having 6 to 10 carbon atoms, such groups being optionally substituted, and when R1 is selected from —S—R, then at least one of R2, R3 and R5 is most preferably selected from halogen; and R1, R2, R3, R4 and R5 are otherwise the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, electron donor groups such as alkoxy having 1-5 carbon atoms or hydroxy, electron acceptor groups selected from cyano, nitro, trifluoroalkyl or amide; alkylamino, benzoyloxy, nitroxy, phenyl or sulpho; and pharmacologically acceptable salts thereof. Compounds described have activity on the melanocortin receptors and have application in the treatment of a wide range of inflammatory, arthritic or central nerve regeneration conditions.
摘要翻译：描述了通式（I）的化合物及其异构体形式，其中n为0,1,2或3，饱和或不饱和; 最优选R 1至R 5中的至少一个表示卤素; R 1，R 2，R 3，R 4和R 5中的至少一个选自-S-R或-COOR，或者R 1 -R 5中的两个或多个包含连接基团，例如-S-（CH 2）m S-，其中m是 1,2或3，并且R选自具有1至5个碳原子的烷基，具有3-6个碳原子的环烷基，羟基和具有6至10个碳原子的芳基，这些基团任选被取代，并且当R 1选自 - S-R，则R 2，R 3和R 5中的至少一个最优选选自卤素; R 1，R 2，R 3，R 4和R 5相同或不同，选自氢，卤素，具有1至5个碳原子的烷基，电子给体基团如具有1-5个碳原子的烷氧基或羟基，电子受体基团选自氰基，硝基，三氟烷基或酰胺; 烷基氨基，苯甲酰氧基，硝酰基，苯基或磺基; 及其药理学上可接受的盐。所描述的化合物对黑皮质素受体具有活性，并且可用于治疗广泛的炎性，关节炎或中枢神经再生条件。

6. 发明申请

US20070231267A1 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands 审中-公开
标题翻译：使用亚苄氨基鸟嘌呤和羟基胍来作为黑皮质素受体配体
公开(公告)号：US20070231267A1
公开(公告)日：2007-10-04
申请号：US11798669
申请日：2007-05-16
申请人： Torbjorn Lundstedt , Anna Skottner , Elisabeth Seifert
发明人： Torbjorn Lundstedt , Anna Skottner , Elisabeth Seifert
IPC分类号： A61K31/155 , A61K31/205 , A61K49/00
CPC分类号： C07C281/16 , A61K31/155 , C07C53/10 , C07C309/30 , C07C309/46 , C07D317/58
摘要： The present invention relates to the use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: wherein X is H or OH; R1, R2, R3, R4 and R5 are the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, electron donor groups such as alkoxy having 1-5 carbon atoms or hydroxy, electron acceptor groups selected from cyano, nitro, trifluoroalkyl or amide; alkylamino, benzoyloxy, nitroxy, phenyl or sulpho; and the pharmacologically active salts thereof.
摘要翻译：本发明涉及通式（I）的化合物作为黑皮质素受体的配体和/或用于治疗黑皮质素系统中的病症的用途：其中X是H或OH; R 1，R 2，R 3，R 4和R 5相同或不同，选自氢，卤素，具有1-5个碳原子的烷基，电子给体基团如具有1-5个碳原子的烷氧基或羟基，电子受体基团选自氰基，硝基，三氟烷基或酰胺; 烷基氨基，苯甲酰氧基，硝酰基，苯基或磺基; 及其药理学活性盐。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式